Article info
PDFArrhythmias and sudden death
Original article
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
- Correspondence to Dr Renato D Lopes, Duke Clinical Research Institute, Room 0311 Terrace Level, 2400 Pratt Street, Durham, NC 27705, USA; renato.lopes{at}duke.edu
Citation
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
Publication history
- Received April 28, 2016
- Revised September 22, 2016
- Accepted September 27, 2016
- First published October 24, 2016.
Online issue publication
January 18, 2021
Article Versions
- Previous version (24 July 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/